We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $22.2B
1-Year Est. Return 58.34%
This Fund
S&P 500
This Quarter Est. Return
+31.13%
1 Year Est. Return
+58.34%
3 Year Est. Return
+153.02%
5 Year Est. Return
+199.78%
10 Year Est. Return
+811.75%
AUM
$22.2B
AUM Growth
+$2.96B
Cap. Flow
-$534M
Cap. Flow %
-2.4%
Top 10 Hldgs %
32.73%
Holding
727
New
37
Increased
291
Reduced
287
Closed
50

Top Buys

Rank Stock Value
1
AVGO icon
Broadcom
AVGO
+$110M
2
ENTG icon
Entegris
ENTG
+$53.1M
3
HLT icon
Hilton Worldwide
HLT
+$45.7M
4
ISRG icon
Intuitive Surgical
ISRG
+$44.3M
5
WDC icon
Western Digital
WDC
+$41.5M

Top Sells

Rank Stock Value
1
MU icon
Micron Technology
MU
+$68.2M
2
JNJ icon
Johnson & Johnson
JNJ
+$67.3M
3
MSFT icon
Microsoft
MSFT
+$64.1M
4
GILD icon
Gilead Sciences
GILD
+$63.1M
5
ON icon
ON Semiconductor
ON
+$62.5M

Sector Composition

Rank Sector Weight
1 Technology 38.31%
2 Healthcare 24.36%
3 Financials 9.42%
4 Communication Services 7.08%
5 Consumer Discretionary 6.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SNEX icon
101
StoneX
SNEX
$8.38B
$46.1M 0.21%
584,099
+403,815
+224% +$30.3M
FIX icon
102
Comfort Systems
FIX
$56.7B
$46M 0.21%
23,255
-3,821
-14% -$6.93M
ELVN icon
103
Enliven Therapeutics
ELVN
$4.35B
$45.9M 0.21%
905,674
+311,595
+52% +$13.2M
ICE icon
104
Intercontinental Exchange
ICE
$90.5B
$45.5M 0.21%
370,292
-75,178
-17% -$11.3M
BAP icon
105
Credicorp
BAP
$30.4B
$45.3M 0.2%
116,400
+5,000
+4% +$1.71M
NTRS icon
106
Northern Trust
NTRS
$34.1B
$45.3M 0.2%
260,614
+127,695
+96% +$21M
USB icon
107
US Bancorp
USB
$98.7B
$45.1M 0.2%
746,783
-16,294
-2% -$913K
MIRM icon
108
Mirum Pharmaceuticals
MIRM
$6.15B
$44M 0.2%
376,143
-88,073
-19% -$8.84M
NBIX icon
109
Neurocrine Biosciences
NBIX
$15.8B
$43.9M 0.2%
260,926
-14,138
-5% -$2.1M
FCX icon
110
Freeport-McMoran
FCX
$104B
$42.9M 0.19%
683,086
+3,588
+0.5% +$231K
AXP icon
111
American Express
AXP
$220B
$42.8M 0.19%
126,799
-64,705
-34% -$20.7M
MAR icon
112
Marriott International
MAR
$87.8B
$42.7M 0.19%
115,208
+1,076
+0.9% +$397K
EQIX icon
113
Equinix
EQIX
$102B
$41.4M 0.19%
39,757
+19,539
+97% +$20.9M
HCA icon
114
HCA Healthcare
HCA
$87.7B
$41.3M 0.19%
106,132
+15,869
+18% +$6.71M
PNC icon
115
PNC Financial Services
PNC
$98B
$41.1M 0.19%
167,031
-1,859
-1% -$416K
CAT icon
116
Caterpillar
CAT
$374B
$41M 0.18%
38,579
-392
-1% -$344K
IDYA icon
117
IDEAYA Biosciences
IDYA
$3.85B
$40.7M 0.18%
1,092,301
-15,407
-1% -$472K
ALL icon
118
Allstate
ALL
$65.6B
$40.5M 0.18%
170,333
-25,619
-13% -$5.57M
CIB icon
119
Grupo Cibest SA
CIB
$23.8B
$39.8M 0.18%
501,456
+260,900
+108% +$18.9M
VRT icon
120
Vertiv
VRT
$108B
$39.3M 0.18%
117,551
-5,567
-5% -$1.77M
FCFS icon
121
FirstCash
FCFS
$9.79B
$38.8M 0.17%
179,645
+28,737
+19% +$6.24M
DE icon
122
Deere & Co
DE
$187B
$38.8M 0.17%
61,234
+12,815
+26% +$7.42M
MDGL icon
123
Madrigal Pharmaceuticals
MDGL
$12.5B
$38.7M 0.17%
72,121
-12,827
-15% -$6.57M
SYF icon
124
Synchrony
SYF
$26B
$38.6M 0.17%
507,690
-35,066
-6% -$2.58M
CYTK icon
125
Cytokinetics
CYTK
$10.1B
$37.7M 0.17%
443,066
+107,858
+32% +$7.74M
3 4
5
6 7

Similar funds

DCP
Darsana Capital Partners New York $22.3B AUM 42.01% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return
TAF
Tredje AP-fonden Se-111 91 Stockholm, Sweden $22.1B AUM 41.68% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $22.1B AUM 45.54% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $22.3B AUM 36.19% 1-Year Est. Return
CIG
Capricorn Investment Group Palo Alto, California $22.5B AUM 50.37% 1-Year Est. Return
ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return

Candriam SCA's Q2 2026 Portfolio in Review

As of Q2 2026, Candriam SCA held 727 positions worth $22.2B, up 15% from $19.3B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Candriam SCA's Q2 2026 filing shows 37 new, 291 increased, 287 reduced and 50 closed positions. Its largest new stake was BBVA Argentina: 1,335,000 shares worth $26.2M. The largest sale was Micron Technology, an estimated $68.2M.

By sector, the portfolio is most concentrated in Technology at 38% of assets, up from 33% a quarter earlier, followed by Healthcare and Financials.

  • Candriam SCA's largest Q2 2026 buy was BBVA Argentina: 1,335,000 shares worth $26.2M.
  • Candriam SCA added most to Broadcom in Q2 2026, an estimated $110M increase.
  • Candriam SCA's biggest Q2 2026 reduction was Micron Technology, cutting an estimated $68.2M.
  • Candriam SCA fully exited Ascendis Pharma A/S in Q2 2026, selling an estimated $52.7M.
  • Candriam SCA's ten largest holdings make up 33% of its $22.2B portfolio in Q2 2026.
  • Candriam SCA opened 37 new positions and closed 50 in Q2 2026.
  • Candriam SCA's portfolio value rose 15% quarter-over-quarter to $22.2B.

Based on Candriam SCA's 13F filing for Q2 2026, filed 13 Aug 2026.